175 related articles for article (PubMed ID: 35214180)
1. Development of Nanosuspension Formulations Compatible with Inkjet Printing for the Convenient and Precise Dispensing of Poorly Soluble Drugs.
Leung DH
Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214180
[TBL] [Abstract][Full Text] [Related]
2. Combining inkjet printing and amorphous nanonization to prepare personalized dosage forms of poorly-soluble drugs.
Cheow WS; Kiew TY; Hadinoto K
Eur J Pharm Biopharm; 2015 Oct; 96():314-21. PubMed ID: 26325060
[TBL] [Abstract][Full Text] [Related]
3. Inkjet printing of small molecules, biologics, and nanoparticles.
Chou WH; Gamboa A; Morales JO
Int J Pharm; 2021 May; 600():120462. PubMed ID: 33711471
[TBL] [Abstract][Full Text] [Related]
4. Nanosuspensions as advanced printing ink for accurate dosing of poorly soluble drugs in personalized medicines.
Pardeike J; Strohmeier DM; Schrödl N; Voura C; Gruber M; Khinast JG; Zimmer A
Int J Pharm; 2011 Nov; 420(1):93-100. PubMed ID: 21889582
[TBL] [Abstract][Full Text] [Related]
5. Inkjet Printing of Drug-Loaded Mesoporous Silica Nanoparticles-A Platform for Drug Development.
Wickström H; Hilgert E; Nyman JO; Desai D; Şen Karaman D; de Beer T; Sandler N; Rosenholm JM
Molecules; 2017 Nov; 22(11):. PubMed ID: 29160839
[TBL] [Abstract][Full Text] [Related]
6. A Pediatrics Utilization Study in The Netherlands to Identify Active Pharmaceutical Ingredients Suitable for Inkjet Printing on Orodispersible Films.
Visser JC; Wibier L; Kiefer O; Orlu M; Breitkreutz J; Woerdenbag HJ; Taxis K
Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32079184
[TBL] [Abstract][Full Text] [Related]
7. Making tablets for delivery of poorly soluble drugs using photoinitiated 3D inkjet printing.
Clark EA; Alexander MR; Irvine DJ; Roberts CJ; Wallace MJ; Yoo J; Wildman RD
Int J Pharm; 2020 Mar; 578():118805. PubMed ID: 31715351
[TBL] [Abstract][Full Text] [Related]
8. Improvement of dissolution rate of indomethacin by inkjet printing.
Wickström H; Palo M; Rijckaert K; Kolakovic R; Nyman JO; Määttänen A; Ihalainen P; Peltonen J; Genina N; de Beer T; Löbmann K; Rades T; Sandler N
Eur J Pharm Sci; 2015 Jul; 75():91-100. PubMed ID: 25817804
[TBL] [Abstract][Full Text] [Related]
9. Inkjet printing of antiviral PCL nanoparticles and anticancer cyclodextrin inclusion complexes on bioadhesive film for cervical administration.
Varan C; Wickström H; Sandler N; Aktaş Y; Bilensoy E
Int J Pharm; 2017 Oct; 531(2):701-713. PubMed ID: 28432016
[TBL] [Abstract][Full Text] [Related]
10. Mechanical characterization and ex vivo evaluation of anticancer and antiviral drug printed bioadhesive film for the treatment of cervical cancer.
Varan C; Şen M; Sandler N; Aktaş Y; Bilensoy E
Eur J Pharm Sci; 2019 Mar; 130():114-123. PubMed ID: 30690187
[TBL] [Abstract][Full Text] [Related]
11. Printing medicines as orodispersible dosage forms: Effect of substrate on the printed micro-structure.
Planchette C; Pichler H; Wimmer-Teubenbacher M; Gruber M; Gruber-Woelfler H; Mohr S; Tetyczka C; Hsiao WK; Paudel A; Roblegg E; Khinast J
Int J Pharm; 2016 Jul; 509(1-2):518-527. PubMed ID: 26541301
[TBL] [Abstract][Full Text] [Related]
12. A step toward development of printable dosage forms for poorly soluble drugs.
Raijada D; Genina N; Fors D; Wisaeus E; Peltonen J; Rantanen J; Sandler N
J Pharm Sci; 2013 Oct; 102(10):3694-704. PubMed ID: 23904182
[TBL] [Abstract][Full Text] [Related]
13. Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine: Preparation, characterization, and in vivo evaluation.
Alshweiat A; Csóka I; Tömösi F; Janáky T; Kovács A; Gáspár R; Sztojkov-Ivanov A; Ducza E; Márki Á; Szabó-Révész P; Ambrus R
Int J Pharm; 2020 Apr; 579():119166. PubMed ID: 32084574
[TBL] [Abstract][Full Text] [Related]
14. Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs.
Kassem MA; Abdel Rahman AA; Ghorab MM; Ahmed MB; Khalil RM
Int J Pharm; 2007 Aug; 340(1-2):126-33. PubMed ID: 17600645
[TBL] [Abstract][Full Text] [Related]
15. Predicting pharmaceutical inkjet printing outcomes using machine learning.
Carou-Senra P; Ong JJ; Castro BM; Seoane-Viaño I; Rodríguez-Pombo L; Cabalar P; Alvarez-Lorenzo C; Basit AW; Pérez G; Goyanes A
Int J Pharm X; 2023 Dec; 5():100181. PubMed ID: 37143957
[TBL] [Abstract][Full Text] [Related]
16. Inkjet Printing of Proteins: an Experimental Approach.
Montenegro-Nicolini M; Miranda V; Morales JO
AAPS J; 2017 Jan; 19(1):234-243. PubMed ID: 27739009
[TBL] [Abstract][Full Text] [Related]
17. Effects of nanosuspension formulations on transport, pharmacokinetics, in vivo targeting and efficacy for poorly water-soluble drugs.
Wang Y; Miao X; Sun L; Song J; Bi C; Yang X; Zheng Y
Curr Pharm Des; 2014; 20(3):454-73. PubMed ID: 23651402
[TBL] [Abstract][Full Text] [Related]
18. Electro-Hydrodynamic Drop-on-Demand Printing of Aqueous Suspensions of Drug Nanoparticles.
Elele E; Shen Y; Boppana R; Afolabi A; Bilgili E; Khusid B
Pharmaceutics; 2020 Oct; 12(11):. PubMed ID: 33138033
[TBL] [Abstract][Full Text] [Related]
19. Impact of Formulation Properties and Process Parameters on the Dispensing and Depositioning of Drug Nanosuspensions Using Micro-Valve Technology.
Bonhoeffer B; Kwade A; Juhnke M
J Pharm Sci; 2017 Apr; 106(4):1102-1110. PubMed ID: 28062204
[TBL] [Abstract][Full Text] [Related]
20. Practical method for preparing nanosuspension formulations for toxicology studies in the discovery stage: formulation optimization and in vitro/in vivo evaluation of nanosized poorly water-soluble compounds.
Komasaka T; Fujimura H; Tagawa T; Sugiyama A; Kitano Y
Chem Pharm Bull (Tokyo); 2014; 62(11):1073-82. PubMed ID: 25366311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
